Mr Lewis has 20 years of experience in the finance and life sciences industries, advising governments, public and private institutions, and emerging companies from around the globe. He has advised over 100 public and private companies, ranging in size and stage of development, to meet their respective investor relations, capital raising and corporate and strategic objectives.
As a key principal architect of The Trout Group LLC's business direction and trajectory, founder of Trout Private Equity and co-founder of Trout Capital LLC and ultimately as a Managing Director/Partner of both groups, he helped to establish the vision and direction for one of the world's leading life science strategic investor relations practices and affiliated boutique investment bank.
Since 2009, Mr Lewis has been active in early company formation in a variety of sectors and has earned Series, 7, 24, 79 and 63 Securities Licenses. In 2014, he co-founded Alsonex Pty Ltd, with the mission to develop a novel approach to the treatment of neurodegenerative disorders driven by complement-mediated pathways: he currently serves as Chief Business Officer.